AzTrials
AzTrials

IVFNCT05924048

Effect of Reducing the Oxygen Concentration From 5% to 2% on ICSI Outcome

A study testing Reducing the Oxygen Concentration From 5% to 2% in people with IVF, run by International Islamic Center for Population Studies and Research at 1 site in Egypt.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

To assess the effect of reducing the oxygen concentration from 5% to 2% on Intracytoplasmic sperm injection (ICSI) outcome. Read more about this study

Who is it for?
Ages 20 to 35 years, women onlyHealthy volunteers can take part
Conditions the study is for
IVF
What is being tested?
Reducing the Oxygen Concentration From 5% to 2%
Could I receive a placebo?
No, everyone receives an active treatment
How many people
196 participants
Where
1 siteEgypt
Study dates
1 Jan 2023to 25 Mar 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 35 years
  • Women only
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Female age 20-35 years. Oocytes with normal morphology.

Who cannot join

  • Embryo number less than 5. Male factor.

Trial locations and contacts

1 site in 1 country.

Ahmed El Sayed Sabry contact

01098609545

ahmedsabry7787@gmail.com

Egypt1 site, 1 recruiting
  • International Islamic Center

    Cairo, 11511

    Amira Badereldin Mehaney, 01226629235, amiraamirabader@hotmail.com

    Recruiting

Other trials in Egypt

About this study

Official title: Effect of Reducing the Oxygen Concentration From 5% to 2% on Intracytoplasmic Sperm Injection (ICSI) Outcome

To assess the effect of reducing the oxygen concentration from 5% to 2% on Intracytoplasmic sperm injection (ICSI) outcome.

Read the detailed description

Oxygen level plays a critical role in reducing the high level of detrimental reactive oxygen species within cells, influences embryonic gene expression, helps with embryo metabolism of glucose, and enhances embryo development from 2PN to the blastocyst stage, the oxygen concentration in the incubator is an important determinant of the in vitro environment that an embryo encounters. The preimplantation embryo consumes oxygen at a relatively constant level from the one-cell through the morula stage, while at the blastocyst stage the consumption is considerably increased. Oxygen plays a role in energy production, but in too high concentrations it may have a toxic effect by the formation of reactive oxygen species. While in vivo oxygen levels range from 1.5 to 8.7% in the fallopian tubes and uterus of several species, in most laboratories in vitro culture of human embryos was traditionally performed under atmospheric oxygen concentrations (~20%) . In mammals, the oxygen (O2) tension in the uterus is lower (2%) than the oviduct (5-7%). This fits with a shift in the metabolic strategy of the embryo after compaction and may have implications for EC in clinical IVF. Indeed, in a recent study utilizing discarded human embryos, blastulation rates were superior when cultured in 2% compared to 5% after day day 3. However, it is exceedingly difficult to control for the myriad factors impacting blastulation when employing discarded material . The technologies available in the early days of IVF, and most likely also for financial reasons, led to the widespread implementation of incubators that used atmospheric air (i.e. 20% oxygen) . Around the turn of the last century, more advanced incubators capable of creating an environment of 5% oxygen, which better resembles the natural

environment for oocytes and embryos, were developed. Currently, in around 60% of the IVF cycles performed worldwide, the embryos are cultured under 5% oxygen . Kaser et al. add to the long history of experimental data evaluating different oxygen levels in embryo culture. They evaluated the impact of a sequential oxygen tension system (5% oxygen from day 1 to day 3; 2% oxygen from day 3 to day 5) in extended culture . The effect of oxygen level during embryo culture on pregnancy and live birth rates is less straightforward. Although most studies found an improvement in embryo quality when culturing embryos under 5% oxygen . This discrepancy is partly explained by lack of power due to small sample sizes in some studies. When data are pooled in meta-analyses, the overall effect favours culture under 5% oxygen . Another explanation for the inconsistent results among the studies could be due to the differences in duration of exposure, until cleavage or blastocyst stage. When data in the meta-analyses were stratified for duration of culture, there was no effect of oxygen on pregnancy or live birth rates after 2-3 days of culture. After culture to the blastocyst stage, however, culture under 5% oxygen resulted in improved ongoing pregnancy. In the previous studies reported that culture under 5% O2 results in significantly more human surplus embryos reaching the blastocyst stage, as well as a higher proportion of blastocysts consisting of a normal number of cells.

in the human, indirect evidence exists that a low O2 tension of 5% appears to enhance the blastulation rate of surplus embryos .

A reduction in oxygen tension from atmospheric to more physiologic levels is beneficial for the mammalian blastocyst, in terms of a higher cell number and decreased apoptosis, less DNA fragmentation and less oxidative stress. During this highly metabolically active period of growth of the embryo and differentiation into trophectoderm (TE) and inner cell mass (ICM), this decrease in oxygen may protect against oxidative stress .

Conditions
IVF
Being tested
Reducing the Oxygen Concentration From 5% to 2%

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Reducing the Oxygen Concentration From 5% to 2%Other

    Effect of Reducing the Oxygen Concentration From 5% to 2% in arm 1.

Study groups in NCT05924048
Study groupRoleWhat they receive
Group of 2% oxygen concentration.ExperimentalIncubate human embryo at 2% oxygen concentration.
Receives: Other: Reducing the Oxygen Concentration From 5% to 2%
Group of 5% oxygen concentration.No interventionIncubate human embryo at 5% oxygen concentration.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Number and grad of embryos which exposed to oxygen concentration 2% .

    Evaluate embryo quality at day 5

    Measured: 1.3 year

Secondary outcomes (1)
  1. Clinical pregnancy rate for examined subject.

    Compare the two arms in clinical pregnancy.

    Measured: 1.5 Year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 Jun 2023
  2. Study start1 Jan 2023
  3. Primary completion27 Jan 2024 (estimated)
  4. Study completion25 Mar 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Masking
Quadruple blind
Who is masked
Participant, Care provider, Investigator, Outcomes assessor
Enrolment
196 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05924048
Sponsor's protocol ID
O2 level in human embryo
Status last verified
Jun 2023
First submitted
18 Jun 2023
Last updated
11 Jul 2023
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Bahceci M, Ciray HN, Karagenc L, Ulug U, Bener F. Effect of oxygen concentration during the incubation of embryos of women undergoing ICSI and embryo transfer: a prospective randomized study. Reprod Biomed Online. 2005 Oct;11(4):438-43. doi: 10.1016/s1472-6483(10)61136-4.

    PubMed 16274603
  • Bontekoe S, Mantikou E, van Wely M, Seshadri S, Repping S, Mastenbroek S. Low oxygen concentrations for embryo culture in assisted reproductive technologies. Cochrane Database Syst Rev. 2012 Jul 11;2012(7):CD008950. doi: 10.1002/14651858.CD008950.pub2.

    PubMed 22786519
  • Christianson MS, Zhao Y, Shoham G, Granot I, Safran A, Khafagy A, Leong M, Shoham Z. Embryo catheter loading and embryo culture techniques: results of a worldwide Web-based survey. J Assist Reprod Genet. 2014 Aug;31(8):1029-36. doi: 10.1007/s10815-014-0250-z. Epub 2014 Jun 10.

    PubMed 24913025
  • Gomes Sobrinho DB, Oliveira JB, Petersen CG, Mauri AL, Silva LF, Massaro FC, Baruffi RL, Cavagna M, Franco JG Jr. IVF/ICSI outcomes after culture of human embryos at low oxygen tension: a meta-analysis. Reprod Biol Endocrinol. 2011 Nov 1;9:143. doi: 10.1186/1477-7827-9-143.

    PubMed 22044493
  • Guerin P, El Mouatassim S, Menezo Y. Oxidative stress and protection against reactive oxygen species in the pre-implantation embryo and its surroundings. Hum Reprod Update. 2001 Mar-Apr;7(2):175-89. doi: 10.1093/humupd/7.2.175.

    PubMed 11284661
  • Dumoulin JC, Meijers CJ, Bras M, Coonen E, Geraedts JP, Evers JL. Effect of oxygen concentration on human in-vitro fertilization and embryo culture. Hum Reprod. 1999 Feb;14(2):465-9. doi: 10.1093/humrep/14.2.465.

    PubMed 10099995
  • Kaser DJ, Bogale B, Sarda V, Farland LV, Williams PL, Racowsky C. Randomized controlled trial of low (5%) versus ultralow (2%) oxygen for extended culture using bipronucleate and tripronucleate human preimplantation embryos. Fertil Steril. 2018 Jun;109(6):1030-1037.e2. doi: 10.1016/j.fertnstert.2018.02.119.

    PubMed 29935641
  • Kea B, Gebhardt J, Watt J, Westphal LM, Lathi RB, Milki AA, Behr B. Effect of reduced oxygen concentrations on the outcome of in vitro fertilization. Fertil Steril. 2007 Jan;87(1):213-6. doi: 10.1016/j.fertnstert.2006.05.066. Epub 2006 Nov 1.

    PubMed 17081523
  • Kovacic B, Sajko MC, Vlaisavljevic V. A prospective, randomized trial on the effect of atmospheric versus reduced oxygen concentration on the outcome of intracytoplasmic sperm injection cycles. Fertil Steril. 2010 Jul;94(2):511-9. doi: 10.1016/j.fertnstert.2009.03.077. Epub 2009 May 5.

    PubMed 19409544
  • Meintjes M, Chantilis SJ, Douglas JD, Rodriguez AJ, Guerami AR, Bookout DM, Barnett BD, Madden JD. A controlled randomized trial evaluating the effect of lowered incubator oxygen tension on live births in a predominantly blastocyst transfer program. Hum Reprod. 2009 Feb;24(2):300-7. doi: 10.1093/humrep/den368. Epub 2008 Oct 16.

    PubMed 18927130
  • Nastri CO, Nobrega BN, Teixeira DM, Amorim J, Diniz LMM, Barbosa MWP, Giorgi VSI, Pileggi VN, Martins WP. Low versus atmospheric oxygen tension for embryo culture in assisted reproduction: a systematic review and meta-analysis. Fertil Steril. 2016 Jul;106(1):95-104.e17. doi: 10.1016/j.fertnstert.2016.02.037. Epub 2016 Mar 21.

    PubMed 27012651

Questions about this trial

What is this clinical trial studying?

A study testing Reducing the Oxygen Concentration From 5% to 2% in people with IVF, run by International Islamic Center for Population Studies and Research at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 11 Jul 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Ahmed El Sayed Sabry (01098609545, ahmedsabry7787@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Number and grad of embryos which exposed to oxygen concentration 2% . (time frame: 1.3 year). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05924048, which also lists 11 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Jul 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in